Clinical Trial Update: Hematoporphyrin Photodynamic Therapy for Esophageal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating hematoporphyrin-based photodynamic therapy for esophageal cancer is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Hematoporphyrin (hematoporphyrin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Esophageal Cancer, Photodynamic Therapy | Phase 4 | Status: NOT_YET_RECRUITING